resources
AAPS Understanding drug release mechanisms of metformin using complementary in vitro dissolution tools
Poster
Preview - This content has been restricted to logged in users only.
SDi2 to investigate the effect of formulation differences on drug release for immediate (IR) and extended (ER) release Metformin tablets
Poster
Purpose The purpose of this study was to utilize proprietary dissolution technologies (SDi2) to investigate the effect of formulation differences on drug release for immediate (IR) and extended (ER) release Metformin tablets.
Application Notes
Conserving biorelevant enzymatic activity during in vitro subcutaneous drug testing
Webinar
Barriers and solutions for mimicking an in vivo extracellular environment with in vitro tools
Previous post
Next post